INS and metabolic syndrome: It is well documented that testosterone replacement therapy improves these conditions in patients with manifest testosterone deficiency [16, 17] and numerous studies have demonstrated increased insulin sensitivity, decreased systemic inflammation and recovery of components of the metabolic syndrome [18–20].